Global Primary Care POC Diagnostics Market 2026–2030: Forecast Insights for Business Planning
Uncover key drivers, emerging technologies, and competitive movements shaping the primary care poc diagnostics market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Primary Care POC Diagnostics Market from 2026 to 2030?
The primary care poc diagnostics market size has experienced strong growth in recent years. This market is projected to expand from $17.38 billion in 2025 to $18.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the rising prevalence of infectious and chronic diseases, broader adoption of glucose and cardiometabolic testing, the expansion of primary care diagnostic capabilities, increased use of over-the-counter diagnostic products, and improved accessibility of rapid tests.
The primary care poc diagnostics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be primarily attributed to factors such as the increasing demand for decentralized diagnostic solutions, the rising incorporation of AI-enabled diagnostics, the broadening of telehealth-supported testing services, a heightened emphasis on preventive health screening, and increased investments in personalized diagnostic approaches. Key trends observed within this forecast period include the expanding adoption of rapid diagnostic testing, the growing integration of digital point-of-care devices, an escalating demand for at-home diagnostic kits, the expansion of multiplex testing platforms, and a strengthened focus on early disease detection.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp
What Drivers Are Affecting Demand In The Primary Care POC Diagnostics Market?
The primary care POC diagnostics market is expected to see growth propelled by the increasing prevalence of infectious diseases. These conditions stem from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. They spread directly or indirectly between individuals through contact with contaminated surfaces, air, water, or vectors like insects. Contributing factors to their widespread nature include poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage. Primary care POC diagnostics are crucial tools in diverse healthcare settings, combating these diseases by enabling early detection, timely treatment, and effective control measures. For instance, in March 2025, the Centers for Disease Control and Prevention (CDC), a US federal agency, reported that tuberculosis cases escalated from 9,622 in 2023 to 10,347 in 2024, an 8% increase, with the incidence rate also climbing from 2.9 to 3.0 per 100,000 population, a 6% rise. Hence, the rising prevalence of infectious diseases is a significant driver for the primary care POC diagnostics market.
Which Segments Are Gaining Traction In The Primary Care POC Diagnostics Market?
The primary care poc diagnostics market covered in this report is segmented –
1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses
Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices
Which Trends Are Guiding The Evolution Of The Primary Care POC Diagnostics Market?
Major companies operating in the primary care POC diagnostics market are focusing on developing advanced microfluidic-based rapid susceptibility testing to enhance timely antibiotic decision-making. Such microfluidic rapid susceptibility testing employs tiny fluid channels to swiftly isolate and cultivate bacteria, enabling early identification of their responsiveness to different antimicrobials and reducing the waiting period for results. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostic solutions company, launched the PA-100 AST System, which features proprietary microfluidic technology. This system can detect bacteria from urine samples in about 15 minutes and provide antimicrobial susceptibility test (AST) results in as little as 30 minutes at the initial clinic visit. The analyzer is compact, desktop-sized, and utilizes reagent cartridges into which samples are directly placed for automatic measurement. Healthcare professionals lacking specialized lab training can operate it easily. By accelerating diagnostics, the device supports appropriate antimicrobial use during first patient visits and assists in the global fight against antimicrobial resistance.
Who Are The Primary Competitors In The Global Primary Care POC Diagnostics Market?
Major companies operating in the primary care poc diagnostics market are Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc, DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care poc diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Primary Care POC Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15642&type=smp
Browse Through More Reports Similar to the Global Primary Care POC Diagnostics Market 2026, By The Business Research Company
Poc Medical Imaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report
Point Of Care Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Clinical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
